Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer
Margarita González‐Vallinas(Universidad de Valladolid), Ana Ramı́rez de Molina(Madrid Institute for Advanced Studies), Teodoro Vargas(Madrid Institute for Advanced Studies), Paloma Cejas(Dana-Farber Cancer Institute), Cristina Aguayo(Hospital Universitario La Paz), Susana Molina(Madrid Institute for Advanced Studies), Jesús Herránz(Madrid Institute for Advanced Studies), Guillermo Reglero(Madrid Institute for Advanced Studies), Ana Custodio(Hospital Universitario La Paz), Jaime Feliú(Hospital Universitario La Paz), Emilio Burgos(Hospital Universitario Infanta Sofía), Juan Moreno‐Rubio(Hospital La Paz Institute for Health Research)
Cited by 33
Related Papers
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
|Cancer Research|2020|215